Kir4.2 potassium channel as a novel drug target for Parkinson’s disease inflammation
Griffith University researchers have identified the Kir4.2 (KCNJ15) potassium channel as a promising new biological target for Parkinson’s disease (PD) inflammation. A PD-specific loss-of-function genetic variant (KCNJ15...